Breckenridge submits Paragraph IV certifications for seven ANDAs Breckenridge Pharmaceutical.

Breckenridge submits Paragraph IV certifications for seven ANDAs Breckenridge Pharmaceutical, Inc.announced that it has submitted Paragraph IV certifications for seven different Abbreviated New Drug Applications through the 2011 twelve months and intends to send at least five every year for the next many years. Breckenridge continues to consider new ANDA possibilities from development partners, whereby Breckenridge will submit the applications as PIV’s and wholly manage the resulting litigation.To assess the effects of exhaustion and rest disruption on cognitive function in long-term survivors of childhood tumor, Kevin Krull, PhD, of St. Jude Children’s Analysis Hospital in Memphis and his group evaluated a questionnaire filled out by 1,426 people from the Childhood Malignancy Survivor Study. Related StoriesCrucial change in solitary DNA base predisposes children to aggressive type of cancerOvarian cancer patients with a history of oral contraceptive make use of have better outcomesNew antenna-like device makes breast cancer surgery less complicated for surgeonsCognitive impairment was identified in over 20 % of survivors.